Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Metastatic Brain Neuroendocrine Tumor Originating from the Liver

  • Lee, Guk Jin (Department of Internal Medicine, The Catholic University of Korea, Bucheon St. Mary's Hospital) ;
  • Jo, Kwang Wook (Department of Neurosurgery, The Catholic University of Korea, Bucheon St. Mary's Hospital) ;
  • Kim, Jeana (Department of Hospital Pathology, The Catholic University of Korea, Bucheon St. Mary's Hospital) ;
  • Park, Il Young (Department of Surgery, The Catholic University of Korea, Bucheon St. Mary's Hospital)
  • Received : 2014.09.11
  • Accepted : 2014.12.17
  • Published : 2015.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

A 67-year-old male presented with left temporal hemianopsia and left hemiparesis. A contrast-enhanced magnetic resonance image revealed a $4.5{\times}3.5{\times}5.0cm$ rim-enhancing mass with central necrosis and associated edema located in the left occipital lobe. Of positron emission tomography and abdominal computed tomography, a 9-cm mass with poor enhancement was found in the right hepatic lobe. Craniotomy and right hemihepatectomy was performed. The resected specimen showed histological features and immunochemical staining consistent with a metastatic neuroendocrine tumor (NET). Four months later, the tumors recurred in the brain, liverand spinal cord. Palliative chemotherapy with etoposide and cisplatin led to complete remission of recurred lesions, but the patient died for pneumonia. This is the first case of a metastatic brain NET originating from the liver. If the metastatic NET of brain is suspicious, investigation for primary lesion should be considered including liver.

Keywords

References

  1. Akahoshi T, Higashi H, Tsuruta S, Tahara K, Matsumoto T, Takeuchi H, et al. : Primary neuroendocrine carcinoma coexisting with hemangioma in the liver : report of a case. Surg Today 40 : 185-189, 2010 https://doi.org/10.1007/s00595-009-4018-5
  2. Burger PC, Green SB : Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59 : 1617-1625, 1987 https://doi.org/10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X
  3. Donadon M, Torzilli G, Palmisano A, Del Fabbro D, Panizzo V, Maggioni M, et al. : Liver resection for primary hepatic neuroendocrine tumours : report of three cases and review of the literature. Eur J Surg Oncol 32 : 325-328, 2006 https://doi.org/10.1016/j.ejso.2005.11.017
  4. Hlatky R, Suki D, Sawaya R : Carcinoid metastasis to the brain. Cancer 101 : 2605-2613, 2004 https://doi.org/10.1002/cncr.20659
  5. Huang YQ, Xu F, Yang JM, Huang B : Primary hepatic neuroendocrine carcinoma : clinical analysis of 11 cases. Hepatobiliary Pancreat Dis Int 9 : 44-48, 2010
  6. Iwao M, Nakamuta M, Enjoji M, Kubo H, Fukutomi T, Tanabe Y, et al. : Primary hepatic carcinoid tumor : case report and review of 53 cases. Med Sci Monit 7 : 746-750, 2001
  7. Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, et al. : Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol 40 : 313-318, 2010 https://doi.org/10.1093/jjco/hyp173
  8. Johnson LA, Lavin P, Moertel CG, Weiland L, Dayal Y, Doos WG, et al. : Carcinoids : the association of histologic growth pattern and survival. Cancer 51 : 882-889, 1983 https://doi.org/10.1002/1097-0142(19830301)51:5<882::AID-CNCR2820510522>3.0.CO;2-8
  9. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW : Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 10 : 1171-1175, 2003 https://doi.org/10.1245/ASO.2003.04.533
  10. Lin CW, Lai CH, Hsu CC, Hsu CT, Hsieh PM, Hung KC, et al. : Primary hepatic carcinoid tumor : a case report and review of the literature. Cases J 2 : 90, 2009 https://doi.org/10.1186/1757-1626-2-90
  11. Modlin IM, Lye KD, Kidd M : A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 : 934-959, 2003 https://doi.org/10.1002/cncr.11105
  12. Moertel CG, Kvols LK, O’Connell MJ, Rubin J : Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68 : 227-232, 1991 https://doi.org/10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I
  13. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E : Gastric carcinoids and neuroendocrine carcinomas : pathogenesis, pathology, and behavior. World J Surg 20 : 168-172, 1996 https://doi.org/10.1007/s002689900026
  14. Ruckert RI, Ruckert JC, Dorffel Y, Rudolph B, Muller JM : Primary hepatic neuroendocrine tumor : successful hepatectomy in two cases and review of the literature. Digestion 60 : 110-116, 1999 https://doi.org/10.1159/000007635
  15. Staren ED, Gould VE, Warren WH, Wool NL, Bines S, Baker J, et al. : Neuroendocrine carcinomas of the colon and rectum : a clinicopathologic evaluation. Surgery 104 : 1080-1089, 1988
  16. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC : Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004 : analysis of 625 cases. Br J Neurosurg 21 : 496-500, 2007 https://doi.org/10.1080/02688690701449251
  17. Zhang A, Xiang J, Zhang M, Zheng S : Primary hepatic carcinoid tumours : clinical features with an emphasis on carcinoid syndrome and recurrence. J Int Med Res 36 : 848-859, 2008 https://doi.org/10.1177/147323000803600428

Cited by

  1. Contribution of Immune-Mediated Paraneoplastic Syndromes to Neurological Manifestations of Neuroendocrine Tumours: A Retrospective Study vol.111, pp.1, 2021, https://doi.org/10.1159/000506400